CSafe is committed to delivering new innovations to the biopharma industry and has laid out plans to integrate a new temperature setpoint for its active bulk air cargo container—the CSafe RKN.

CSafe RKNs with the -20°C setpoint capability will be available for lease in early 2024. CSafe said the RKN design requires minimal adjustment to accommodate the new -20°C temperature setpoint, which will limit the need for additional customer training.

The company will begin offering CSafe RKNs with the new frozen temperature setpoint on the control panel early next year. The new design will feature predictive and real-time analysis, visibility to condition data, lower energy active system and can be used by wide-body aircraft, ground transportation and warehouse operations.

“Our engineering team designed our RKN in a way that we could easily add frozen temperature setpoints in the future,” said CSafe chief operating officer, Tom Weir.

“Every CSafe RKN is built with patented high-performance VIP insulation and an innovative air recirculation system that envelops the entire payload.

“Combined with our industry-leading preventive maintenance rebuild program and support from our global service network, these technologies and service programs have delivered reliable temperature control and exceptional battery life for 15 years.”

CSafe CEO, Patrick Schafer, commented: “We are passionate about ensuring life-saving and life-enhancing medicines can be safely delivered to patients around the world. With this latest capability, CSafe offers an unmatched range of temperature profiles that can meet virtually every requirement for customers shipping these high-value therapies.”